Cargando…

Long-Term Effectiveness and Safety of Dutasteride versus Finasteride in Patients with Male Androgenic Alopecia in South Korea: A Multicentre Chart Review Study

BACKGROUND: Dutasteride improves hair growth compared with finasteride in male androgenic alopecia (AGA) and is well tolerated. However, real-world evidence for long-term dutasteride use in AGA is lacking. OBJECTIVE: To describe baseline characteristics, treatment patterns and long-term safety and e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Choi, Gwang-Seong, Sim, Woo-Young, Kang, Hoon, Huh, Chang Hun, Lee, Yang Won, Shantakumar, Sumitra, Ho, Yu-Fan, Oh, Eun-Jeong, Duh, Mei Sheng, Cheng, Wendy Y., Bobbili, Priyanka, Thompson-Leduc, Philippe, Ong, Gary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9561294/ https://www.ncbi.nlm.nih.gov/pubmed/36198626 http://dx.doi.org/10.5021/ad.22.027

Ejemplares similares

Preventive and Therapeutic Efficacy of Finasteride and Dutasteride in TRAMP Mice
por: Opoku-Acheampong, Alexander B., et al.
Publicado: (2013)

The efficacy and safety of dutasteride compared with finasteride in treating men with androgenetic alopecia: a systematic review and meta-analysis
por: Zhou, Zhongbao, et al.
Publicado: (2019)

Development of finasteride polymer microspheres for systemic application in androgenic alopecia
por: Kim, Ju Hee, et al.
Publicado: (2019)

The Different Reduction Rate of Prostate-Specific Antigen in Dutasteride and Finasteride
por: Choi, Yong Hyeuk, et al.
Publicado: (2010)

A population-based study of the risk of osteoporosis and fracture with dutasteride and finasteride
por: Antoniou, Tony, et al.
Publicado: (2018)

Bone Health Risks Associated with Finasteride and Dutasteride Long-Term Use
por: Sirufo, Maria Maddalena, et al.
Publicado: (2021)

Mesotherapy with Dutasteride in the Treatment of Androgenetic Alopecia
por: Saceda-Corralo, David, et al.
Publicado: (2017)

Does treatment with dutasteride or finasteride has impact on renal morphology? Experimental study
por: da Silva, Marcello Henrique Araújo, et al.
Publicado: (2021)

Hematuria and Hematospermia Associated with the Use of Finasteride for the Treatment of Androgenic Alopecia: A Case Report
por: Fouda, Abdel-Motaal M., et al.
Publicado: (2017)

Transcutaneous application of ultrasound enhances the effects of finasteride in a murine model of androgenic alopecia
por: Kim, Jaeho, et al.
Publicado: (2022)

Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride
por: Kiguradze, Tina, et al.
Publicado: (2017)

Health Risks Associated with Long-Term Finasteride and Dutasteride Use: It's Time to Sound the Alarm
por: Traish, Abdulmaged M.
Publicado: (2020)

The impact of finasteride and dutasteride treatments on proliferation, apoptosis, androgen receptor, 5α-reductase 1 and 5α-reductase 2 in TRAMP mouse prostates
por: Opoku-Acheampong, Alexander B., et al.
Publicado: (2017)

Safety and Tolerability of the Dual 5-Alpha Reductase Inhibitor Dutasteride in the Treatment of Androgenetic Alopecia
por: Choi, Gwang Seong, et al.
Publicado: (2016)

Prospective randomized study of sexual function in men taking dutasteride for the treatment of androgenetic alopecia
por: Tsai, Tsen‐Fang, et al.
Publicado: (2018)

The Effect of Finasteride and Dutasteride on the Growth of WPE1-NA22 Prostate Cancer Xenografts in Nude Mice
por: Opoku-Acheampong, Alexander B., et al.
Publicado: (2012)

Rates of prostate surgery and acute urinary retention for benign prostatic hyperplasia in men treated with dutasteride or finasteride
por: Kuiper, Josephina G., et al.
Publicado: (2016)

The efficacy and safety of dutasteride and finasteride in patients with benign prostatic hyperplasia: a systematic review and meta-analysis
por: Li, Yao, et al.
Publicado: (2022)

Genetic variations associated with response to dutasteride in the treatment of male subjects with androgenetic alopecia
por: Rhie, Arang, et al.
Publicado: (2019)

Influence of Postoperative Finasteride Therapy on Recurrence of Gynecomastia After Mastectomy in Men Taking Finasteride for Alopecia
por: Lee, Seung Geun, et al.
Publicado: (2019)

Comparing Clinical and Economic Outcomes Associated with Early Initiation of Combination Therapy of an Alpha Blocker and Dutasteride or Finasteride in Men with Benign Prostatic Hyperplasia in the United States
por: DerSarkissian, Maral, et al.
Publicado: (2016)

Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia
por: Khera, Mohit, et al.
Publicado: (2020)

The effect of GGC and CAG repeat polymorphisms on the androgen receptor gene in response to finasteride therapy in men with androgenetic alopecia
por: Ghassemi, Mohammadreza, et al.
Publicado: (2019)

Evaluation of long‐term efficacy of finasteride in Korean men with androgenetic alopecia using the basic and specific classification system
por: Shin, Jung‐Won, et al.
Publicado: (2018)

The corpus cavernosum after treatment with dutasteride or finasteride: A histomorphometric study in a benign prostatic hyperplasia rodent model
por: Da Silva, Marcello H A, et al.
Publicado: (2018)

Suicidal risk associated with finasteride versus dutasteride among men treated for benign prostatic hyperplasia: nationwide cohort study
por: Laanani, Moussa, et al.
Publicado: (2023)

Change in hair growth-related gene expression profile in human isolated hair follicles induced by 5-alpha reductase inhibitors – dutasteride and finasteride – in the presence of testosterone
por: Hatanaka, Toshiki, et al.
Publicado: (2021)

Evaluation of hair regrowth after minoxidil and dutasteride tattooing in men with androgenetic alopecia
por: Ragi, Sara D., et al.
Publicado: (2023)

Efficacy and safety of dutasteride compared with finasteride in treating males with benign prostatic hyperplasia: A meta-analysis of randomized controlled trials
por: Zhou, Zhongbao, et al.
Publicado: (2020)

Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
por: Shin, Yu Seob, et al.
Publicado: (2019)

Topical Finasteride: A Comprehensive Review of Androgenetic Alopecia Management for Men and Women
por: Keerti, Akshunna, et al.
Publicado: (2023)

Low-Level Laser Therapy for Androgenic Alopecia
por: Tin, Sim Sai, et al.
Publicado: (2014)

Androgen Receptor (AR) Gene (CAG)n and (GGN)n Length Polymorphisms and Symptoms in Young Males With Long-Lasting Adverse Effects After Finasteride Use Against Androgenic Alopecia
por: Cauci, Sabina, et al.
Publicado: (2016)

Finasteride-mediated hair regrowth and reversal of atrophy in a patient with frontal fibrosing alopecia
por: Donovan, Jeff C.
Publicado: (2015)

Immunohistochemical Evaluation of Androgen Receptor and Nerve Structure Density in Human Prepuce from Patients with Persistent Sexual Side Effects after Finasteride Use for Androgenetic Alopecia
por: Di Loreto, Carla, et al.
Publicado: (2014)

Real-world Treatment Patterns, Outcomes, and Healthcare Resource Utilization in Newly Treated Korean Patients With Asthma: A Retrospective Cohort Study
por: Choi, Nam-Kyong, et al.
Publicado: (2022)

Finasteride nano-transferosomal gel formula for management of androgenetic alopecia: ex vivo investigational approach
por: Ahmed, Osama AA, et al.
Publicado: (2018)

Preparation and optimization of aloe ferox gel loaded with Finasteride-Oregano oil nanocubosomes for treatment of alopecia
por: Hosny, Khaled M., et al.
Publicado: (2022)

Drug Treatment for Androgenetic Alopecia: First Italian Questionnaire Survey on What Dermatologists Think about Finasteride
por: Sorbellini, Elisabetta, et al.
Publicado: (2018)

Adherence to National Comprehensive Cancer Network Guidelines for BRCA testing among high risk breast Cancer patients: a retrospective chart review study
por: Bobbili, Priyanka, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9jq22kde2bi9rsa4voopkf4grn